This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Nonpracticing entity beats Cisco, Palo Alto, Fortinet bid to stay US patent case

By Melissa Ritti ( April 16, 2025, 18:27 GMT | Insight) -- US Judge Rodney Gilstrap is keeping litigation over computer networking patents on track in Texas, this week denying a joint motion by Cisco, Palo Alto Network and Fortinet to stay the case while one of the three Croga Innovations patents-in-suit is scrutinized in an inter partes review by the Patent Trial and Appeal Board. The order is inconsequential, now, to Palo Alto Network — in an order issued yesterday, Gilstrap dismissed the US-based cybersecurity multinational after it purportedly reached a settlement with the patent owner, a nonpracticing entity.A planned October 2025 US trial in Croga Innovations’ patent infringement case against Cisco and Fortinet will remain on the calendar of Judge Rodney Gilstrap of the US Eastern District of Texas, following his denial this week of a defense motion to stay....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections